DK0793721T3 - Peptider, der er i stand til at binde sig til GAP-proteinets SH3-domæne, nukleotidsekvenser, der koder derfor, fremstilling og anvendelse deraf - Google Patents

Peptider, der er i stand til at binde sig til GAP-proteinets SH3-domæne, nukleotidsekvenser, der koder derfor, fremstilling og anvendelse deraf

Info

Publication number: DK0793721T3
Authority: DK; Denmark
Prior art keywords: domain; binding; production; nucleotide sequences; sequences encoding
Prior art date: 1994-11-22

Application number

DK95941126T

Other languages

English (en)

Inventor

Fabien Schweighoffer

Fabienne Parker

Bruno Tocque

Marc Duchesne

Didier Faucher

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-11-22

Filing date

1995-11-22

Publication date

2006-01-30

1994-11-22 Priority claimed from FR9413955A external-priority patent/FR2727116B1/fr

1995-05-16 Priority claimed from FR9505753A external-priority patent/FR2734266B1/fr

1995-11-22 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2006-01-30 Application granted granted Critical

2006-01-30 Publication of DK0793721T3 publication Critical patent/DK0793721T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
- C07K14/4706—Guanosine triphosphatase activating protein, GAP
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

DK95941126T 1994-11-22 1995-11-22 Peptider, der er i stand til at binde sig til GAP-proteinets SH3-domæne, nukleotidsekvenser, der koder derfor, fremstilling og anvendelse deraf DK0793721T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9413955A FR2727116B1 (fr)	1994-11-22	1994-11-22	Peptides capables de se lier au domaine sh3 de la proteine gap, sequences nucleotidiques codant pour ces peptides, leur preparation et utilisation
FR9505753A FR2734266B1 (fr)	1995-05-16	1995-05-16	Peptides capables de se lier au domaine sh3 de la proteine gap sequences nucleotidiques codant pour ces peptides, leur preparation et utilisation

Publications (1)

Publication Number	Publication Date
DK0793721T3 true DK0793721T3 (da)	2006-01-30

Family

ID=26231549

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95941126T DK0793721T3 (da)	1994-11-22	1995-11-22	Peptider, der er i stand til at binde sig til GAP-proteinets SH3-domæne, nukleotidsekvenser, der koder derfor, fremstilling og anvendelse deraf

Country Status (18)

Country	Link
US (1)	US5886150A (da)
EP (1)	EP0793721B1 (da)
JP (2)	JPH10509044A (da)
AT (1)	ATE305037T1 (da)
AU (1)	AU713937B2 (da)
BR (1)	BR9510067A (da)
CA (1)	CA2204438A1 (da)
CZ (1)	CZ292538B6 (da)
DE (1)	DE69534471T2 (da)
DK (1)	DK0793721T3 (da)
ES (1)	ES2248800T3 (da)
FI (1)	FI972170L (da)
HU (1)	HU221410B1 (da)
IL (1)	IL116026A (da)
MX (1)	MX9703364A (da)
NO (1)	NO972313D0 (da)
SK (1)	SK287034B6 (da)
WO (1)	WO1996016169A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2780062B1 (fr) *	1998-06-17	2000-07-28	Rhone Poulenc Rorer Sa	Anticorps monoclonaux diriges contre la proteine g3bp, et leurs utilisations
CZ302155B6 (cs)	1998-10-23	2010-11-18	Kirin-Amgen Inc.	Sloucenina, která se váže na mpl receptor, zpusob její výroby, farmaceutická kompozice s jejím obsahem, polynukleotid, vektor a hostitelská bunka
US6864355B1 (en)	2000-05-02	2005-03-08	Yale University	Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
AU2001266070A1 (en) *	2000-06-16	2001-12-24	Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V.	Method for identifying apoptosis-modified proteins
EP1377828A4 (en) *	2001-04-10	2006-11-15	Childrens Medical Center	METHODS OF ANALYZING AND MARKING PROTEIN-PROTEIN INTERACTIONS
US20050069999A1 (en) *	2001-07-09	2005-03-31	Sharma Sreenath V	Sh3 domain binding inhibitors
JPWO2003006060A1 (ja) *	2001-07-09	2004-10-28	協和醗酵工業株式会社	Ｓｈ３ドメイン結合阻害剤
AUPR721101A0 (en) *	2001-08-23	2001-09-13	University Of Queensland, The	Nucleic acid and polypeptide linked to breast cancer
MX2007000216A (es) *	2004-07-08	2007-03-15	Amgen Inc	Peptidos terapeuticos.
WO2006036834A2 (en) *	2004-09-24	2006-04-06	Amgen Inc.	MODIFIED Fc MOLECULES
US8008453B2 (en)	2005-08-12	2011-08-30	Amgen Inc.	Modified Fc molecules
JO3324B1 (ar)	2006-04-21	2019-03-13	Amgen Inc	مركبات علاجية مجففة بالتبريد تتعلق بالعصارة الهضمية
US11237168B2 (en) *	2019-06-26	2022-02-01	St. Jude Children's Research Hospital	Method for identifying modulators of G3BP activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA894726B (en) *	1988-06-27	1990-03-28	Akzo Nv	Coccidiosis vaccine
AU652724B2 (en) *	1989-08-21	1994-09-08	Chiron Corporation	Peptides from GTPase-activating protein (GAP) and diagnostic and therapeutic use thereof
EP0496162A3 (en) *	1990-12-24	1993-09-01	Merck & Co. Inc.	Peptide inhibitors of ras-gap interaction
FR2694296B1 (fr) *	1992-07-30	1994-09-02	Rhone Poulenc Rorer Sa	Peptides inhibant l'activité des protéines ras, préparation et utilisation.
WO1994016069A2 (en) *	1993-01-15	1994-07-21	Schering Corporation	Ras associated gap proteins

1995
- 1995-11-16 IL IL11602695A patent/IL116026A/xx not_active IP Right Cessation
- 1995-11-22 DE DE69534471T patent/DE69534471T2/de not_active Expired - Lifetime
- 1995-11-22 DK DK95941126T patent/DK0793721T3/da active
- 1995-11-22 AU AU42636/96A patent/AU713937B2/en not_active Ceased
- 1995-11-22 JP JP8516632A patent/JPH10509044A/ja not_active Ceased
- 1995-11-22 AT AT95941126T patent/ATE305037T1/de not_active IP Right Cessation
- 1995-11-22 ES ES95941126T patent/ES2248800T3/es not_active Expired - Lifetime
- 1995-11-22 EP EP95941126A patent/EP0793721B1/fr not_active Expired - Lifetime
- 1995-11-22 CZ CZ19971545A patent/CZ292538B6/cs not_active IP Right Cessation
- 1995-11-22 BR BR9510067A patent/BR9510067A/pt not_active Application Discontinuation
- 1995-11-22 CA CA002204438A patent/CA2204438A1/fr not_active Abandoned
- 1995-11-22 SK SK629-97A patent/SK287034B6/sk not_active IP Right Cessation
- 1995-11-22 MX MX9703364A patent/MX9703364A/es not_active IP Right Cessation
- 1995-11-22 HU HU9702079A patent/HU221410B1/hu not_active IP Right Cessation
- 1995-11-22 US US08/836,791 patent/US5886150A/en not_active Expired - Fee Related
- 1995-11-22 WO PCT/FR1995/001539 patent/WO1996016169A1/fr active IP Right Grant
1997
- 1997-05-21 FI FI972170A patent/FI972170L/fi not_active Application Discontinuation
- 1997-05-21 NO NO972313A patent/NO972313D0/no not_active Application Discontinuation
2005
- 2005-10-25 JP JP2005309422A patent/JP2006122049A/ja active Pending

Also Published As

Publication number	Publication date
EP0793721A1 (fr)	1997-09-10
IL116026A (en)	2005-08-31
JP2006122049A (ja)	2006-05-18
NO972313L (no)	1997-05-21
IL116026A0 (en)	1996-01-31
DE69534471T2 (de)	2006-06-22
CZ154597A3 (en)	1997-10-15
AU713937B2 (en)	1999-12-16
CA2204438A1 (fr)	1996-05-30
FI972170A0 (fi)	1997-05-21
AU4263696A (en)	1996-06-17
NO972313D0 (no)	1997-05-21
HU221410B1 (en)	2002-09-28
MX9703364A (es)	1997-08-30
ES2248800T3 (es)	2006-03-16
HUT77029A (hu)	1998-03-02
JPH10509044A (ja)	1998-09-08
EP0793721B1 (fr)	2005-09-21
US5886150A (en)	1999-03-23
FI972170L (fi)	1997-05-21
BR9510067A (pt)	1997-12-30
SK287034B6 (sk)	2009-10-07
CZ292538B6 (cs)	2003-10-15
DE69534471D1 (de)	2006-02-02
WO1996016169A1 (fr)	1996-05-30
ATE305037T1 (de)	2005-10-15
SK62997A3 (en)	1998-02-04

Publication	Publication Date	Title
ATE389724T1 (de)	2008-04-15	Menschliche dnase i hyperaktive varianten
DK0793721T3 (da)	2006-01-30	Peptider, der er i stand til at binde sig til GAP-proteinets SH3-domæne, nukleotidsekvenser, der koder derfor, fremstilling og anvendelse deraf
DE68914664D1 (de)	1994-05-19	Gereinigte ubiquitin-hydrolase, diese kodierende dns-sequenzen und ihre verwendung zur gewinnung von polypeptiden.
DK0719328T3 (da)	2000-11-13	Genet GRB 3-3, varianter deraf og anvendelse deraf
ATE443761T1 (de)	2009-10-15	Rtd receptor
MX9806041A (es)	1998-11-30	Proteina purificada sr-p70.
SE9602822D0 (sv)	1996-07-19	New receptor
DK0939769T3 (da)	2006-03-13	Vertebrat-Smoothened-proteiner
ATE215123T1 (de)	2002-04-15	Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
PE20399A1 (es)	1999-03-05	Muteina ob
ATE230027T1 (de)	2003-01-15	Menschliche dnase i varianten
ES2059801T3 (es)	1994-11-16	Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas.
DK0938555T3 (da)	2005-05-23	Konstruktioner og komplekser af cyclin E
BG101847A (en)	1998-07-31	Human dnase i variants
HUP0102540A2 (hu)	2001-10-28	Új angiotenzin-receptor, eljárás előállítására és alkalmazása
ATE104344T1 (de)	1994-04-15	Gereinigte ubiquitin-hydrolase, diese kodierende dns-sequenzen und ihre verwendung zur gewinnung von polypeptiden.
ECSP972331A (es)	1998-12-14	Muteinas de la obesidad